Bacterial degradation of the anti-depressant drug fluoxetine produces trifluoroacetic acid and fluoride ion
- PMID: 34755212
- DOI: 10.1007/s00253-021-11675-3
Bacterial degradation of the anti-depressant drug fluoxetine produces trifluoroacetic acid and fluoride ion
Abstract
Fluoxetine (FLX) is a blockbuster drug with annual sales in the billions of dollars. Its widespread use has resulted in its detection in water courses, where it impacts aquatic life. Investigations on the biodegradation of FLX by microorganisms are important, since augmentation of secondary wastewater treatment by an effective degrader may be one method of improving the drug's removal. In this paper, we demonstrate that common environmental bacteria can use FLX as a sole carbon and energy source. Investigations into the metabolites formed using fluorine-19 nuclear magnetic resonance spectroscopy (19F NMR) and gas chromatography-mass spectrometry indicated that the drug was initially hydrolysed to yield 4-(trifluoromethyl)phenol (TFMP) and 3-(methylamino)-1-phenylpropan-1-ol. Since the fluorometabolite accumulated, the bacteria presumably used the latter compound for carbon and energy. Further growth studies revealed that TFMP could also be used as a sole carbon and energy source and was most likely catabolised via meta-cleavage, since semialdehyde products were detected in culture supernatants. The final products of the degradation pathway were trifluoroacetate and fluoride ion; the former is a dead-end product and was not further catabolised. Fluoride ion most likely arises owing to spontaneous defluorination of the meta-cleavage products that were shown to be photolabile.Key points• Bacteria can use FLX and TFMP as sole carbon and energy sources for their growth.• Biodegradation produces fluorometabolites that were detected by 19F NMR and GC-MS.• Trifluoroacetic acid and fluoride ion were identified as end products.
Keywords: 4-(Trifluoromethyl)phenol; Biodegradation; Fluoride ion; Fluoxetine; Photodegradation; Trifluoroacetate.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Alexandrino DAM, Ribeiro I, Pinto LM, Cambra R, Oliveira RS, Pereira F, Carvalho MF (2018) Biodegradation of mono-, di- and trifluoroacetate by microbial cultures with different origins. New Biotechnol 43:23–29. https://doi.org/10.1016/j.nbt.2017.08.005 - DOI
-
- Amorim CL, Carvalho MF, Afonso CMM, Castro PML (2013) Biodegradation of fluoroanilines by the wild strain Labrys portucalensis. Int Biodeterior Biodegradation 80:10–15. https://doi.org/10.1016/j.ibiod.2013.02.001 - DOI
-
- Benfield P, Heel RC, Lewis SP (1986) Fluoxetine - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive-illness. Drugs 32(6):481–508. https://doi.org/10.2165/00003495-198632060-00002 - DOI - PubMed
-
- Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, La Point TW, Huggett DB (2003) Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 52(1):135–142. https://doi.org/10.1016/s0045-6535(03)00103-6 - DOI - PubMed
-
- Carvalho MF, Jorge RF, Pacheco CC, De Marco P, Castro PML (2005) Isolation and properties of a pure bacterial strain capable of fluorobenzene degradation as sole carbon and energy source. Environ Microbiol 7(2):294–298. https://doi.org/10.1111/j.1462-2920.2004.00714.x - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous